Compound 214
Identifiers
- Canonical SMILES:
CC(C)(C)C[C@H]1N[C@H]([C@H](c2cccc(Cl)c2)[C@]11C(=O)Nc2cc(Cl)c(F)cc12)C(=O)NCC[C@H](O)CO
- IUPAC name:
(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chlorophenyl)-N-[(3S)-3,4-dihydroxybutyl]-5'-(2,2-dimethylpropyl)-5-fluoro-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide
- InChi:
InChI=1S/C27H32Cl2FN3O4/c1-26(2,3)12-21-27(17-10-19(30)18(29)11-20(17)32-25(27)37)22(14-5-4-6-15(28)9-14)23(33-21)24(36)31-8-7-16(35)13-34/h4-6,9-11,16,21-23,33-35H,7-8,12-13H2,1-3H3,(H,31,36)(H,32,37)/t16-,21+,22-,23+,27+/m0/s1
- InChiKey:
UNXQGBMZYKHQCO-SARUBHRKSA-N
External links
168318275 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 2 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 7.88 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 551.18 g/mol | |||
HBA | 7 | |||
HBD | 5 | |||
HBA + HBD | 12 | |||
AlogP | 3.41 | |||
TPSA | 110.69 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 2 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
19928922 | 7 | MDM2 Q00987 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 6.79 | |
19928922 | 7 | MDM2 Q00987 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 7.88 | |
19928922 | 7 | MDM2 Q00987 |
|
Cellular assay | Proliferation assay | SJSA-1 cells | pIC50 (half maximal inhibitory concentration, -log10) | 6.15 |
19928922 | 7 | MDM2 Q00987 |
|
Cellular assay | Proliferation assay | Saos-2 cells | pIC50 (half maximal inhibitory concentration, -log10) | 4.81 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.8636 | SAR-405838 | DB12541 | |
0.6818 | Milademetan | DB15257 | |
0.5342 | Degarelix | DB06699 | |
0.5294 | Mosapramine | DB13676 | |
0.5285 | SLV-334 | DB15356 | |
0.5126 | Daglutril | DB05796 | |
0.5124 | Acyline | DB11906 | |
0.5089 | Idasanutlin | DB12325 | |
0.5073 | Abarelix | DB00106 | |
0.5044 | MK-3207 | DB12424 | |
0.5030 | (3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE | DB07090 | |
0.5030 | (3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE | DB07222 | |
0.4974 | OPC-51803 | DB05838 | |
0.4922 | OPC-14523 | DB05422 | |
0.4922 | Brimapitide | DB15231 |